Life Sciences Report

With the groundbreaking of the Berlin Center for Gene and Cell Therapies and the opening of the Berlin Center for Advanced Therapies at Charité, Berlin-Brandenburg is stepping up efforts to position itself as a leading location for advanced and personalized therapies. The field is an umbrella for a range of next-generation medical approaches, including rapidly growing gene and cell therapies as well as regenerative therapies aimed at restoring damaged tissues and organs.

Berlin Brandenburg is moving into precision medicine. With the opening of Der Simulierte Mensch (Si-M) and the Einstein Center for Early Disease Interception in Berlin-Wedding in spring 2026, the region has gained two new hubs linking human-based disease models, single-cell multi-omics, spatial biology, and AI-driven diagnostics. Their shared aim is to detect disease at its earliest molecular stages, enabling intervention before symptoms even emerge.

Neurotech is reshaping the diagnosis and treatment of neurological and psychiatric disorders. In Berlin Brandenburg, the field is moving from research into practical application through brain-computer interfaces, digital therapies and non-invasive diagnostic tools. Neurotech is opening up new therapeutic and diagnostic pathways for conditions including Alzheimer's disease, Parkinson's disease, epilepsy, stroke and traumatic brain injuries as well as mental disorders.

Artificial intelligence (AI) is transforming healthcare at a rapid pace. It is changing how health data are collected, interpreted and applied across areas ranging from basic research and drug development to diagnostics, clinical decision support, disease management, and administrative medical tasks. Few regions are as well positioned to drive this shift as Berlin Brandenburg. The capital region brings together research institutions, hospitals, technology developers and companies working across these different stages of medical AI, supported by a growing infrastructure for testing, validation and clinical translation.